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Introduction
In eukaryotic cells, replication of the genome involves a highly 
orchestrated assembly of proteins onto the DNA (Méndez and 
Stillman, 2003; Sclafani and Holzen, 2007). First, the origin 
recognition complex binds to sequences of DNA that will func-
tion as initiation points for replication. After this binding, the 
origin recognition complex appears to serve as a landing pad for 
the replication proteins Cdc6 and Cdt1. Thereupon, these pro-
teins  mediate  loading  of  the  minichromosome  maintenance 
complex onto the DNA, which results in formation of the prerep-
lication complex (Diffley, 2004). The minichromosome mainte-
nance proteins are critical elements of the helicase activity that 
separates the two strands of DNA for replication (Pacek et al., 
2006; Ilves et al., 2010).
Full assembly of the replicative helicase and its ultimate 
activation require the participation of additional structural and 
regulatory proteins, including two conserved kinases. Studies in 
yeast have established the paradigm for this process (Sclafani and 
Holzen,  2007;  Remus  and  Diffley,  2009; Tanaka  and Araki, 
2010). In particular, numerous replication proteins, includ-
ing Dpb11, Sld2, Sld3, and Cdc45, also bind at or near replica-
tion origins. In the course of events leading to replication, 
the Dbf4-dependent kinase and Cdk carry out key phosphoryla-
tions of proteins in this network (Araki, 2010; Labib, 2010). 
The role of S phase Cdk (S-Cdk) activity appears to be espe-
cially pivotal in this scheme (Botchan, 2007; Tanaka et al., 
2007a,b; Zegerman and Diffley, 2007). It has been demonstrated 
that S-Cdk phosphorylates Sld2 and Sld3. These modifications 
enable docking of Sld2 and Sld3 with two distinct pairs of 
BRCA1 C terminus (BRCT) repeats within Dpb11. These steps 
eventually lead to the recruitment of Cdc45 as an activator of the 
replicative  helicase.  Functional  studies  have  established  that 
these phosphorylations of Sld2 and Sld3 are minimally neces-
sary for S-Cdk to promote the initiation of S phase (Tanaka et al., 
2007b; Zegerman and Diffley, 2007).
A question of ongoing interest has been whether these 
regulatory events operate in a conserved manner in more com-
plex organisms. In vertebrate cells, the closest relative of Dpb11 is 
a protein known as TopBP1 (Garcia et al., 2005). TopBP1 is a 
more elaborate protein that contains eight BRCT repeats, as op-
posed to only four in Dpb11. Nonetheless, TopBP1 also facili-
tates the incorporation of Cdc45 into the replicative machinery and 
is thus necessary for DNA replication (Van Hatten et al., 2002; 
T
reslin,  a  TopBP1-interacting  protein,  is  necessary 
for deoxyribonucleic acid (DNA) replication in ver-
tebrates. Association between Treslin and TopBP1 
requires cyclin-dependent kinase (Cdk) activity in Xeno-
pus laevis egg extracts. We investigated the mechanism 
and  functional  importance  of  Cdk  for  this  interaction 
using both X. laevis egg extracts and human cells. We 
found that Treslin also associated with TopBP1 in a Cdk-
regulated  manner  in  human  cells  and  that  Treslin  was 
phosphorylated within a conserved Cdk consensus target 
sequence (on S976 in X. laevis and S1000 in humans). 
Recombinant human Cdk2–cyclin E also phosphorylated 
this residue of Treslin in vitro very effectively. Moreover, 
a mutant of Treslin that cannot undergo phosphorylation 
on  this  site  showed  significantly  diminished  binding  to 
TopBP1. Finally, human cells harboring this mutant were 
severely deficient in DNA replication. Collectively, these 
results  indicate  that  Cdk-mediated  phosphorylation  of 
Treslin during S phase is necessary for both its effective 
association with TopBP1 and its ability to promote DNA 
replication in human cells.
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binding of Treslin to TopBP1 in asynchronous cells (unpub-
lished data). From these studies, we conclude that there is some 
basal association of Treslin and TopBP1 throughout much, if 
not all, of the cell cycle, but this interaction increases substan-
tially at S phase. This increase is sensitive to roscovitine, which 
suggests that it depends on Cdk activity. These results are gen-
erally consistent with what we observed previously in X. laevis egg 
extracts. Although p27 clearly inhibited the binding of TopBP1 
Hashimoto and Takisawa, 2003). On the other hand, a conclusive 
assignment of vertebrate proteins as functional analogues of Sld2 
and Sld3 has not been straightforward.
The vertebrate RecQ4 protein displays some limited homol-
ogy with yeast Sld2 and is necessary for DNA replication, but this 
protein differs from Sld2 in several respects (Sangrithi et al., 
2005; Matsuno et al., 2006). Recently, a protein called Treslin 
(also known as Ticrr) has emerged as an excellent candidate for 
a vertebrate counterpart of Sld3 (Kumagai et al., 2010; Sansam 
et al., 2010). This protein associates specifically with TopBP1 
and is an essential replication protein. Two other proteins, 
namely GEMC1 and DUE-B, have also been proposed as can-
didates for vertebrate Sld3 (Balestrini et al., 2010; Chowdhury 
et al., 2010). However, among these proteins, only Treslin dis-
plays any, albeit limited, homology with yeast Sld3 (Fu and 
Walter, 2010; Sanchez-Pulido et al., 2010). In this paper, we in-
vestigate this issue further by asking whether phosphorylation 
of Treslin by S-Cdk is critical for its replication-initiating func-
tion. We have found that phosphorylation of a single conserved 
site in Treslin by S-Cdk regulates both its binding to TopBP1 
and its ability to promote DNA replication. Thus, these studies 
establish that there is a crucial regulatory relationship between 
S-Cdk activity and Treslin for promoting DNA replication in 
vertebrate cells.
Results
Treslin associates with TopBP1 in a cell 
cycle–regulated manner in human cells
Previously, we demonstrated that the interaction between Tres-
lin and TopBP1 in Xenopus laevis egg extracts depends on S-Cdk 
activity. The evidence was that treatment of egg extracts with 
the Cdk inhibitor p27 caused a substantial reduction in the bind-
ing of TopBP1 to Treslin (Kumagai et al., 2010). However, it has 
also been reported that treatment of asynchronous human cells 
with the Cdk inhibitor roscovitine does not inhibit this inter-
action (Sansam et al., 2010). The cell cycle in X. laevis egg ex-
tracts contains only two phases (S and M), which is characteristic 
of early embryonic cell cycles. On the other hand, somatic cell 
cycles also contain G1 and G2 phases. Therefore, we hypothe-
sized that it may be more difficult to detect cell cycle–regulated 
changes in the binding of TopBP1 to Treslin in asynchronous 
somatic cells.
To address this possibility, we synchronized human U2OS 
cells by treating them with nocodazole and using the mitotic 
shake-off procedure (Fig. 1). We observed that the cells entered 
S phase at 9–12 h after release from the nocodazole-induced 
mitotic arrest, as indicated by the incorporation of EdU into the 
DNA (Fig. 1 A). As expected, roscovitine completely blocked entry 
into S phase. Next, we measured the binding of Treslin to TopBP1 
as a function of time during the cell cycle (Fig. 1, B and C). We 
found that there was some binding throughout the time course. 
However, there was a significant increase in binding of Treslin 
to TopBP1 at 9–12 h after removal of nocodazole during the time 
of  replication.  Significantly,  this  increase  was  abrogated  by 
treatment with roscovitine (Fig. 1, B and C). On the other hand, 
we found it difficult to observe an effect of roscovitine on the 
Figure 1.  Treslin and TopBP1 interact in a Cdk-regulated manner in human 
U2OS cells. (A) U2OS cells were arrested at M phase with nocodazole, 
isolated from plates by shake-off, and released into fresh nocodazole-free 
medium. 25 µM roscovitine was added to one of two duplicate cultures 
at 3 h after the release (arrow). Cells were harvested every 3 h. DNA 
replication was monitored by incorporation of EdU in cells incubated in the 
absence (circles) or presence (triangles) of roscovitine. Results are from one 
representative experiment. A second experiment gave similar results. 
(B) Cell lysates were immunoprecipitated with control or anti-Treslin anti-
bodies as indicated. Cell lysates (top) and immunoprecipitates (IP; bottom) 
were immunoblotted for TopBP1 and Treslin. (C) Quantitation of the results 
from the bottom portion of B. Results are from one representative experi-
ment. A second experiment gave similar results.997 Regulation of Treslin by S-Cdk • Kumagai et al.
X. laevis and human Treslin undergo 
phosphorylation on a conserved Cdk site
Next, we searched for Cdk phosphorylation sites in Treslin. 
Toward this end, we examined the sequence of Treslin for well-
conserved potential Cdk phosphorylation sites (especially in the 
region corresponding to the 893–1,257 fragment of human 
Treslin). It is well known that Cdks have a marked preference to 
phosphorylate Ser-Pro/Thr-Pro (SP/TP) motifs. As depicted in 
Fig. 3 A, we noticed that Treslin contains two especially well-
conserved potential Cdk phosphorylation sites (at T944 and S976 
in X. laevis and at T968 and S1000 in humans). These sites are 
relatively close to one another. Moreover, we noted that the se-
quence in this area of Treslin displays some similarity with the 
yeast Sld3 proteins. This area of homology is distinct from 
those previously identified (Sanchez-Pulido et al., 2010).
In parallel, we also examined the phosphorylation of Tre-
slin by mass spectrometry (MS). For this purpose, we initially 
analyzed X. laevis Treslin that had been isolated from S phase 
X. laevis egg extracts (see Materials and methods). Among sev-
eral  phosphorylated  peptides,  we  detected  three  peptides 
containing phosphorylated S976 in X. laevis Treslin: K.GRPS-
ESNSNISIVEEpSPEK.E, K.GRPSESNSNISIVEEpSPEKEIR.
D, and N.ISIVEEpSPEK.E. In Fig. 3 B, we have presented a 
part of the MS/MS spectrum acquired from a doubly charged 
precursor with m/z 1069.9827. The hit had a peptide ion score 
of 71, and its peptide mass matched with better than 1 ppm 
accuracy to amino acids 961–979 from Treslin (K.GRPSESNS-
NISIVEEpSPEK.E). Thus,  S976  of Treslin  undergoes  phos-
phorylation in egg extracts. On the other hand, we were not able 
to observe phosphorylation of T944, even though we could 
detect overlapping peptides that cover the sequence in this 
  region (unpublished data).
S1000 of human Treslin is necessary for 
binding to TopBP1
Based on this information, we decided to prepare point mutants 
of Treslin. Initially, we chose to mutate sites within the human 
protein to take advantage of the functional assays that we had 
developed in human cells. Toward this end, we mutated T968, 
S1000, or both to Ala in the context of the 893–1,257 fragment 
of human Treslin. We expressed these polypeptides in U2OS 
cells and assayed binding to the BRCT I–II fragment of TopBP1. 
As shown in Fig. 4 (A and B), the S1000A mutant of Treslin 
showed significantly reduced binding to TopBP1. In contrast, 
the T986A mutant bound as well as the wild-type fragment of 
Treslin to TopBP1. The double mutant (which we named TSAA) 
displayed a similar level of binding as the single S1000A mutant.
To provide further validation of these results, we made use 
of the X. laevis egg extract system. For this purpose, we prepared 
wild-type and mutant forms of the human 893–1,257 fragment 
in bacteria and then incubated these polypeptides in S phase 
extracts of X. laevis eggs containing reconstituted nuclei. Sub-
sequently, we prepared nuclear lysates from the extracts and 
incubated  these  lysates  with  the  FLAG-tagged  BRCT  I–II 
  fragment of TopBP1. Finally, we reisolated the fragment of 
TopBP1 with anti-FLAG antibody beads and detected binding 
of Treslin with anti-Myc antibodies. As shown in Fig. 4 (C and D), 
to Treslin in egg extracts, it did not completely abolish the inter-
action (Kumagai et al., 2010). Overall, our results indicate that 
the interaction between Treslin and TopBP1 is regulated by Cdk 
activity in multiple systems.
Mapping of the regions in Treslin that bind 
to TopBP1
Having established that binding of Treslin to TopBP1 is under 
the control of Cdk activity in both X. laevis egg extracts and human 
cells, we sought to understand the mechanism of this regulation. 
Evidence has been presented that TopBP1 in egg extracts is not 
a direct functional target of Cdks (Hashimoto and Takisawa, 
2003). Moreover, it is well established in budding yeast that Sld3, 
the putative functional analogue of Treslin, is directly phos-
phorylated in a functionally critical manner by S-Cdk (Tanaka 
et al., 2007b; Zegerman and Diffley, 2007). Therefore, we pos-
tulated that Treslin might also be a direct substrate of S-Cdk. To 
address this question effectively, we felt that it would be impor-
tant to identify first what region of Treslin is responsible for 
interacting with TopBP1.
To  elucidate  the  region  of Treslin  that  associates  with 
TopBP1, we developed a binding assay in human cells. For this 
purpose, we expressed Myc-tagged constructs of Treslin in human 
U2OS cells. Next, we prepared lysates from the cells and incu-
bated the lysates with an exogenously added FLAG-tagged 
fragment of TopBP1 containing BRCT domains I–II. As we 
previously demonstrated, this region of TopBP1 is both neces-
sary and sufficient for binding Treslin (Kumagai et al., 2010). 
Finally, we reisolated the TopBP1 fragment with anti-FLAG 
antibody beads and immunoblotted with anti-Myc antibodies. 
As shown in Fig. 2 A, full-length Treslin-Myc bound well to the 
BRCT I–II fragment. Initially, we found that a large N-terminal 
fragment of Treslin (residues 1–1,257) bound well to TopBP1, 
whereas a C-terminal fragment (residues 1,253–1,909) was de-
fective for binding (Fig. 2, A and B). We proceeded to dissect 
the N-terminal fragment in further detail. We eventually found 
that a fragment containing residues 893–1,257 bound quite well 
to TopBP1. Truncation mutants with further deletions from 
either end of this fragment (e.g., residues 956–1,257 or 893–1,052) 
bound noticeably less well to TopBP1 (Fig. 2, A and B; and not 
depicted). Thus, most, if not all, of the 893–1,257 region is nec-
essary for optimal binding.
In the course of these experiments, we also found that 
there is another distinct TopBP1-interacting domain in the more 
N-terminal region of Treslin. For example, a fragment containing 
residues 1–822, which does not overlap at all with the 893–1,257 
fragment, also bound significantly to the TopBP1 (Fig. 2, A and B). 
However, the binding of this fragment was noticeably weaker 
than the 893–1,257 fragment. In further analyses, we observed 
that shorter N-terminal fragments (e.g., residues 1–463) bound 
as well as the 1–822 fragment. However, mutants with more exten-
sive deletions, such as the 1–247 and 1–143 fragments, could not 
bind to TopBP1. Overall, we conclude that binding to TopBP1 
involves at least two discontinuous regions of Treslin that con-
tain residues 1–463 and 893–1,257. However, the latter fragment 
binds more strongly and thus is presumably relatively more impor-
tant in the overall interaction with TopBP1.JCB • VOLUME 193 • NUMBER 6 • 2011   998
It is known that many substrates of Cdks possess an amino 
acid sequence that allows docking with cyclin (Schulman et al., 
1998; Loog and Morgan, 2005). This sequence is known as 
the RXL (Arg-X-Leu) or Cy (cyclin binding) motif. We noted 
that human Treslin contains an RXL motif (RNL) at positions 
the wild-type and T968A versions of the fragment bound very 
well to TopBP1. In contrast, the S1000A mutant displayed se-
verely reduced binding to TopBP1. For comparison, the Cdk 
inhibitor p27 caused a similar degree of inhibition in the bind-
ing of the wild-type 893–1,257 fragment to TopBP1.
Figure 2.  Deletion studies of the regions in Treslin that interact with the BRCT I–II domains of TopBP1. (A) Full-length Treslin-Myc (lanes 1, 7, and 8) and 
deletion mutants containing the indicated portions of Treslin (lanes 2–6 and 9–13) were transiently expressed in U2OS cells. Cell lysates (lanes 1–6) were 
incubated in the absence (lane 7) or presence (lanes 8–13) of a FLAG-tagged fragment of TopBP1 containing BRCT domains I–II. The incubations also 
contained anti-FLAG antibodies bound to protein G beads. The beads were reisolated, washed, and processed for immunoblotting with anti-Myc (top) and 
anti-FLAG antibodies (bottom). (B, top) Results of multiple sequence alignments of full-length Treslin using the Kalign program. Dark blue lines represent 
amino acids that are identical in Treslin from human, X. laevis, chicken, and zebrafish. Light blue lines represent amino acids that are identical in two or 
three out of these four species. Asterisks denote SP/TP motifs that have been conserved in all four species. Red asterisks indicate SP/TP motifs that are 
conserved in yeast Sld3 (Fig. 3 A). RXL indicates the location of a putative cyclin-interacting motif. Green lines indicate homology detected by Sanchez-
Pulido et al. (2010) between Treslin and Sld3. (bottom) Summary of the abilities of various fragments of Treslin to interact with the BRCT I–II domain of 
TopBP1. Quantitation was performed from several experiments by measuring with the Odyssey imaging system the amounts of fragments of Treslin that 
bound to the BRCT I–II fragment of TopBP1. The designations on the right are as follows: , <1% input Treslin bound to TopBP1; +, 3–6% input bound; 
and ++, >10% input bound.999 Regulation of Treslin by S-Cdk • Kumagai et al.
Cdk2–cyclin E could phosphorylate the wild-type version of 
this peptide effectively (Fig. 5, C and D). In contrast, the corre-
sponding S1000A mutant of this polypeptide was not phosphory-
lated significantly by Cdk2–cyclin E. Inclusion of roscovitine 
in the kinase assay blocked phosphorylation of the wild-type 
polypeptide. From these experiments, we conclude that S1000 
of Treslin is a direct target of S-Cdk activity. It appears that 
S-Cdk can phosphorylate additional sites in the 893–1,257 frag-
ment of Treslin, at least in cell-free incubations. However, these 
phosphorylations do not appear to have a determinative role in 
the binding of TopBP1.
We also addressed the issue of whether S1000 of human 
Treslin is actually phosphorylated in human cells. Significantly, 
this residue has been identified as an in vivo site of phosphory-
lation in a survey of the phosphoproteome in a human Jurkat 
T cell leukemia line (Mayya et al., 2009). To complement this 
information,  we  also  generated  antibodies  against  a  peptide 
from Treslin containing phosphorylated S1000 (anti–phospho-
S1000 antibodies). These antibodies recognized the wild-type 
version of the 893–1,257 fragment of Treslin that had been in-
cubated in vitro with Cdk2–cyclin E but did not react with the 
S1000A mutant of this peptide (Fig. 5 E). This reactivity of the 
antibodies  with  this  peptide  was  abolished  by  inclusion  of 
roscovitine or p27 during the incubation with the kinase.
913–915, relatively close to S1000 (Fig. 2 B). This motif is well 
conserved in homologues of Treslin in other species. Accord-
ingly, we mutated this sequence by changing both R913 and L915 
to Ala (to create the ANA mutant). We found that the ANA 
  mutant of the 893–1,257 fragment bound as poorly to TopBP1 
as the S1000A mutant did (Fig. 4, C and D).
Treslin is a direct substrate of S-Cdk
Next, we asked whether Treslin (particularly, S1000 of Tres-
lin) could serve as a direct substrate of S-Cdk activity. For this 
purpose, we prepared human recombinant Cdk2–cyclin E by 
expression in Sf9 insect cells. Next, we incubated wild-type 
and mutant forms of the 893–1,257 fragment with this kinase 
in the presence of -[
32P]ATP. We observed that Cdk2–cyclin E 
could phosphorylate the 893–1,257 fragment very well (Fig. 5, 
A and B). The Cdk inhibitors p27 and roscovitine completely 
blocked the phosphorylation. Nonetheless, the T968A, S1000A, 
and TSAA mutants were still good substrates of Cdk2–cyclin E.
The  893–1,257  fragment  contains  23  SP/TP  motifs. 
Therefore, we reasoned that remaining motifs might be phos-
phorylated during the in vitro kinase assays. To address more pre-
cisely the issue of whether S1000 could serve as a substrate, we 
prepared a fusion of GST with residues 989–1,011 of Treslin, 
which contain only this potential Cdk site. We observed that 
Figure 3.  Analysis of the phosphorylation of Treslin. (A) Amino acids 893–1,257 of human Treslin and the corresponding portions of X. laevis Treslin 
and Treslin homologues from sea anemone (NCBI Protein database accession no. XP_001628252) and Trichoplax adhaerens (NCBI Protein database 
accession no. XP_002111061) were aligned with the C-terminal half of budding yeast and fission yeast Sld3 using the T-Coffee (Tree-based Consistency 
Objective Function for Alignment Evaluation) program. Only the most similar portion of the alignment is shown. Identical and similar residues are shaded in 
black and gray, respectively. The asterisks denote residues that are homologous with T600 and S622 of budding yeast Sld3 (corresponding to T968 and 
S1000 of human Treslin). (B) Part of the MS/MS spectrum corresponding to a peptide containing phosphorylated S976 of X. laevis Treslin. MS analysis 
was performed as described in Materials and methods.JCB • VOLUME 193 • NUMBER 6 • 2011   1000
antibodies  could  efficiently  immunoprecipitate  the  wild-type 
fragment of Treslin but not the S1000A mutant (Fig. 5 G). Col-
lectively, our findings and a previously published study (Mayya 
et al., 2009) indicate that S1000 of human Treslin is phosphory-
lated in vivo.
Human cells harboring S1000A mutant 
forms of Treslin are defective  
for DNA replication
We proceeded to examine whether phosphorylation of Treslin 
on S1000 has a functionally important role in DNA replication 
(Fig. 6, A and B). For these experiments, we used U2OS cell 
We also used the anti–phospho-S1000 antibodies to ana-
lyze Treslin in human cells. These antibodies proved to be too 
weak for detection of Treslin by immunoblotting of cell lysates. 
However, we were able to immunoprecipitate the endogenous Tre-
slin in U2OS cells effectively with the anti–phospho-S1000 
antibodies (Fig. 5 F). Inclusion of the phosphopeptide used for 
generation of the antibodies efficiently abolished this immuno-
precipitation, whereas the nonphosphorylated version of the same 
peptide did not block this pull-down. As described in further detail 
in the next section, we also created stable U2OS T-REx cells that 
can express wild-type and S1000A versions of the 1–1,257 frag-
ment of human Treslin. We found that the anti–phospho-S1000 
Figure 4.  The S1000A mutation affects the 
interaction  of  Treslin  (893–1,257)  with  the   
BRCT I–II fragment of TopBP1. (A) Wild-type (WT) 
Treslin (893–1,257)-Myc (lanes 1, 5, and 6) and 
versions of this fragment containing the point 
mutations  T968A  (lanes  2  and  7),  S1000A 
(lanes 3 and 8), and T968AS1000A (lanes 4 
and 9) were expressed transiently in U2OS 
cells. Interaction with the BRCT I–II fragment of 
TopBP1 was assessed as described in Fig. 2 A.   
(B) Quantitation of the data as shown in A. 
Results (mean ± SD) were compiled from three 
independent  experiments.  (C)  A  His-tagged 
form of human Treslin (893–1,257)-Myc (lanes 
1, 2, and 7–9) and versions of this fragment 
containing the point mutations T968AS1000A 
(lanes 3 and 10), T968A (lanes 4 and 11), 
S1000A (lanes 5 and 12), and R913AL915A 
(lanes 6 and 13) were expressed in bacteria 
and purified with nickel agarose beads. The 
fragments  were  incubated  in  X.  laevis  egg 
extracts containing sperm chromatin. In some 
cases, the extracts also contained p27 (lanes 2 
and 9). After a 60-min incubation, nuclei were 
isolated from the extracts, and nuclear lysates 
were prepared as described in Materials and 
methods.  Nuclear  lysates  (lanes  1–6)  were 
incubated without (lane 7) or with the FLAG-
tagged BRCT I–II fragment of TopBP1 (lanes 
8–13) in the presence of anti-FLAG antibody 
beads. The beads were isolated and immuno-
blotted with anti-Myc (top) and anti-FLAG anti-
bodies (bottom). (D) Quantitation of the data 
as shown in C. Results (mean ± SD) were com-
piled from three independent experiments.1001 Regulation of Treslin by S-Cdk • Kumagai et al.
Figure 5.  Phosphorylation of Treslin on S1000 by Cdk2–cyclin E. (A) Cdk2–cyclin E was incubated in the absence (lane 1) or presence of bacterially pro-
duced wild-type (WT) His6-Treslin (893–1,257; lanes 2–4) or the TSAA (lane 5), T968A (lane 6), or S1000A (lane 7) forms of this fragment. Incubations 
were performed in kinase buffer containing [
32P]ATP. The incubations in lanes 3 and 4 also contained 2 µM GST-p27 and 25 µM roscovitine, respectively. 
Samples were subjected to SDS-PAGE and processed for phosphorimaging (top) and Coomassie blue staining (bottom). (B) Quantitation of 
32P incorpora-
tion in A. Results are from one representative experiment. A second experiment gave similar results. (C) Cdk2–cyclin E was incubated with no substrate 
(lane 1), GST-Treslin(989–1,011) (lanes 2 and 4), or GST-Treslin (989–1,011)-S1000A (lanes 3 and 5) in a buffer containing [
32P]ATP. The incubations 
were performed in the absence (lanes 1–3) or presence of 25 µM roscovitine (lanes 4 and 5). Samples were subjected to SDS-PAGE and processed for 
phosphorimaging (top) and Coomassie blue staining (bottom). (D) Quantitation of 
32P incorporation in C. Results are from one representative experiment. 
A second experiment gave similar results. (E) Wild-type Treslin (893–1,257)-Myc (lanes 1, 3, 5, and 6) and its S1000A mutant (lanes 2 and 4) were 
incubated in the absence (lanes 1 and 2) or presence of Cdk2–cyclin E in a kinase buffer containing 1 mM ATP (lanes 3–6). The incubations in lanes 5 
and 6 contained 25 µM roscovitine and 2 µM GST-p27, respectively. The reaction was stopped with SDS sample buffer. Samples were immunoblotted with 
anti–phospho-S1000 (top) and anti-Myc antibodies (bottom). (F) U2OS cell lysates (lane 1) were immunoprecipitated (IP) with either anti–phospho-S1000 
antibodies (lanes 2–4) or control antibodies (lane 5). The immunoprecipitates were performed in the presence of no additional peptide (lanes 4 and 5) or 
1 µg/ml of the either the immunizing phosphopeptide (lane 2) or the nonphosphorylated form of the same peptide (lane 3). Samples were immunoblotted 
with anti-Treslin antibodies. (G) Lysates from stable U2OS T-REx cell lines (lanes 1 and 2) expressing either wild-type Treslin (1–1,257)-Myc (lanes 1, 3, 5, 7, 
and 9) or the S1000A mutant of this fragment (lanes 2, 4, 6, 8, and 10) were immunoprecipitated with control (lanes 3 and 4) or anti–phospho-S1000 
antibodies (lanes 5–10) in the presence of no additional peptide (lanes 3–6) or 1 µg/ml of either immunizing phosphopeptide (lanes 9 and 10) or non-
phosphorylated peptide (lanes 7 and 8). Samples were processed for immunoblotting with anti-Myc antibodies.JCB • VOLUME 193 • NUMBER 6 • 2011   1002
Figure 6.  S1000 of Treslin is essential for DNA replication. (A) Control U2OS T-REx cells (lanes 1–4) and U2OS T-REx cells harboring wild-type (lanes 
5–8) or S1000A Treslin-Myc (lanes 9–12) were incubated for 24 h in the absence (lanes 1, 3, 5, 7, 9, and 11) or presence of doxycycline (lanes 2, 
4, 6, 8, 10, and 12). Cells were transfected with either control siRNA (lanes 1, 2, 5, 6, 9, and 10) or Treslin siRNA (lanes 3, 4, 7, 8, 11, and 12) 
and incubated for another 72 h. Cell lysates were immunoblotted with anti-Treslin (top), anti-Myc (middle), and anti-tubulin antibodies (bottom). (B) Cells 
were incubated with 10 µM EdU for 1 h. Samples were stained with Click-iT reagent to detect newly synthesized DNA (top), anti-Myc antibodies to 
detect Treslin (middle), and Hoechst 33342 dye to detect total DNA (bottom). Bar, 50 µM. (C) Expression of wild-type (WT) Treslin (lanes 1, 4, and 5), 
Treslin-T968AS1000A (lanes 2 and 6), and Treslin-S1000A (lanes 3 and 7) was induced with 1 µg/ml doxycycline for 24 h. Cell lysates were prepared 
and immunoprecipitated (IP) with either control (lane 4) or anti–human TopBP1 antibodies (lanes 5–7). Samples were immunoblotted with anti-Myc 
(top) or anti-TopBP1 antibodies (bottom). (D) Quantitation of the binding of various forms of Treslin to TopBP1 as shown in C. Results (mean ± SD) were 
compiled from three independent experiments.1003 Regulation of Treslin by S-Cdk • Kumagai et al.
lines capable of expressing recombinant Treslin in a doxycycline-
inducible manner. Previously, we used this strategy to engineer 
cell lines capable of expressing an siRNA-resistant form of 
Treslin that could rescue the siRNA-mediated ablation of 
endogenous Treslin. In these experiments, we used an untagged 
form of Treslin. To facilitate the analysis of mutants, we gener-
ated similar lines that could express a C-terminally Myc-tagged 
form of siRNA-resistant Treslin (Treslin-Myc). As shown in Fig. 6 
(C and D), wild-type Treslin-Myc bound well to the endogenous 
TopBP1 in U2OS cells. In contrast, the S1000A mutant of the 
full-length Treslin-Myc interacted poorly with TopBP1. Likewise, 
the double TSAA mutant showed similarly weak binding.
As  previously  described  (Kumagai  et  al.,  2010),  cells 
treated with Treslin siRNA in the absence of doxycycline showed 
greatly reduced DNA replication (Figs. 6 B and 7 C). Induction 
of wild-type Treslin-Myc with doxycycline resulted in substantial 
restoration of DNA replication. In parallel, we also induced ex-
pression of the S1000A or TSAA mutants of Treslin-Myc in the 
Treslin-ablated cells. In these cases, there was essentially no res-
cue of DNA replication (Figs. 6 B and 7 C; and not depicted).
To pursue these findings further, we also engineered cells 
that harbor inducible forms of the 1–1,257 fragment of Treslin, 
which is sufficient for binding TopBP1. We observed that the 
wild-type  version  of  this  fragment  rescued  DNA  replication 
very effectively in Treslin siRNA–treated cells (Fig. 7, A–C). 
Indeed, the rescue appeared to be somewhat more effective than 
what  we  observed  with  full-length Treslin.  Nonetheless,  the 
S1000A mutant of the 1–1,257 fragment was still unable to 
rescue  DNA  replication  in  the  siRNA-ablated  cells.  Collec-
tively, these results indicate that phosphorylation of S1000 
plays an important role in DNA replication in human cells.
Treslin interacts with Cdc45  
in vertebrate cells
A key characteristic of budding and fission yeast Sld3 is that 
this protein interacts specifically with Cdc45 (Kamimura et al., 
2001; Yabuuchi et al., 2006). To address whether Treslin inter-
acts with Cdc45, we performed binding experiments in human 
cells and X. laevis egg extracts. Because commercially available 
antibodies were relatively ineffective for detecting endogenous 
Cdc45 in human U2OS cells, we decided to express recombinant 
Cdc45 transiently in these cells. We also coexpressed various 
fragments of Treslin in these cells. As shown in Fig. 8 A, we 
could immunoprecipitate recombinant Cdc45 efficiently with 
anti-Cdc45 antibodies. We found that the 1–921 fragment of 
Treslin was coimmunoprecipitated quite well with these anti-
bodies. Significantly, this fragment largely excludes the principal 
TopBP1-interacting, Cdk-regulated domain of Treslin identified 
in this study. In control experiments, there was no Cdc45 or 
Treslin in immunoprecipitates with control antibodies. We could 
not observe good immunoprecipitation of full-length Treslin 
with Cdc45 (unpublished data).
Because we could not detect a complex between endog-
enous Cdc45 and Treslin in human cells, we decided to pursue 
this issue with X. laevis egg extracts. For this purpose, we pre-
pared lysates of nuclei that had been incubated for 45 min in   
interphase egg extracts and then digested these lysates with   
the nuclease Benzonase. Thereafter, we immunoprecipitated the 
clarified digests with anti-Cdc45 and anti-Treslin antibodies 
and finally performed immunoblotting of the immunoprecipitates. 
As shown in Fig. 8 B, we could readily detect Treslin in anti-
Cdc45 immunoprecipitates. There was also a significant, albeit 
lower, amount of Cdc45 in the anti-Treslin immunoprecipitates. 
It is possible that the anti-Treslin antibodies, which were raised 
against the N-terminal region of the protein, may occlude the 
Cdc45-interacting region of Treslin. Collectively, these experi-
ments indicate that vertebrate Treslin, like yeast Sld3, interacts 
specifically with Cdc45. Moreover, Cdc45 appears to associate 
with a portion of these proteins that lies mostly upstream of the 
region that associates with Dpb11/TopBP1 in a Cdk-regulated 
manner (Tanaka et al., 2007b).
Discussion
It is well established that the Cdks are universal regulators of 
cell cycle transitions, but enumeration of the critical targets of 
these enzymes has been an ongoing challenge (Morgan, 1997). 
In the case of the G1/S transition, S-Cdk activity promotes the 
firing of early replication origins at the threshold of S phase 
(Araki, 2010). Subsequent waves of origin firing eventually re-
sult in complete replication of the genome. Recent advances in 
the budding yeast system have indicated that phosphorylation 
of Sld2 and Sld3 by S-Cdk plays a pivotal role in the triggering 
replication (Tanaka et al., 2007b; Zegerman and Diffley, 2007). 
Indeed, these modifications comprise the minimal set of phos-
phorylations by S-Cdk in controlling initiation of replication.
Phosphorylation of Sld2 and Sld3 promotes their asso-
ciation with distinct regions of Dpb11, another important repli-
cation protein. In particular, phosphorylation of Sld2 on T84 
enables interaction with the C-terminal pair of BRCT repeats 
within Dpb11. Likewise, phosphorylation of Sld3 on T600 and 
S622 allows docking with the two N-terminal BRCT domains 
of Dpb11. An important question is whether this type of regula-
tion exists in multicellular organisms, especially vertebrates. As-
sessment of this issue has been somewhat problematic because 
putative homologues of these proteins in higher eukaryotes ap-
pear to be quite different, at least superficially, from their yeast 
counterparts. The best candidate for vertebrate Sld2 is RecQ4 
(Sangrithi et al., 2005; Matsuno et al., 2006). This protein shows 
some sequence similarity with Sld2, associates with TopBP1, 
and is necessary for replication. However, RecQ4, in contrast to 
Sld2, is dispensable for functional incorporation of Cdc45 into 
the replication machinery. Moreover, the binding of RecQ4 to 
TopBP1 is apparently not dependent on Cdk activity.
Recently, several candidates have emerged as potential ver-
tebrate analogues of Sld3, namely Treslin, GEMC1, and DUE-B 
(Balestrini et al., 2010; Chowdhury et al., 2010; Kumagai et al., 
2010; Sansam et al., 2010). All of these proteins associate with 
TopBP1 and are necessary for recruitment of Cdc45 to chromatin. 
GEMC1 appears to be a bona fide Cdk target, and the association 
of Treslin with TopBP1 depends on Cdk activity. However, among 
the three proteins, only Treslin appears to possess any sequence 
homology with Sld3, although this similarity is low and limited to 
a few patches within the proteins (Sanchez-Pulido et al., 2010).JCB • VOLUME 193 • NUMBER 6 • 2011   1004
these regions appears to play a relatively greater role in the 
  interaction. Within this region, we focused our attention on two 
well-conserved and closely spaced SP/TP sites. Our results have 
indicated that phosphorylation of one of these sites (S1000 of 
human Treslin) is critical for both binding of TopBP1 and DNA 
replication. The sequence around this site shows some resem-
blance to the region in budding yeast Sld3 that contains the 
critical sites for S-Cdk. This region was not identified in previous 
In this study, we have sought to gain further insight into 
this issue by asking whether Treslin is a direct regulatory target 
of Cdk activity. Because human and X. laevis Treslin each 
contains dozens of potential Cdk phosphorylation sites, we 
  attempted to narrow down potentially important regions of Tre-
slin by mapping its TopBP1-interacting region. We found that the 
binding of TopBP1 to Treslin is relatively complex in that it in-
volves two discontinuous regions of Treslin. However, one of 
Figure 7.  A C-terminal domain of Treslin is 
dispensable  for  DNA  replication.  (A)  U2OS 
cells  harboring  wild-type  (lanes  1–4)  or 
S1000A  Treslin  (1–1,257)-Myc  (lanes  5–8) 
were incubated for 24 h in the absence (lanes 
1, 3, 5, and 7) or presence of doxycycline 
(lanes 2, 4, 6, and 8). Cells were transfected 
with either control siRNA (lanes 1, 2, 5, and 6) 
or Treslin siRNA (lanes 3, 4, 7, and 8) and 
incubated for another 72 h. Cell lysates were 
immunoblotted with anti-Treslin (top), anti-Myc 
(middle), and anti-tubulin antibodies (bottom). 
(B) Cells treated with siRNA were incubated 
with 10 µM EdU for 1 h and then processed 
for staining with Click-iT reagent (top), anti-
Myc  antibodies  (middle),  and  Hoechst  dye 
DNA (bottom). Bar, 50 µM. (C) Quantitation 
of the data from Figs. 6 B and 7 B. Results 
(mean ± SD) were compiled from three inde-
pendent experiments.1005 Regulation of Treslin by S-Cdk • Kumagai et al.
divergence at the primary sequence level. Nonetheless, we believe 
that it is reasonable to consider Treslin as the genuine functional 
counterpart of budding yeast Sld3 in vertebrate cells.
A  question  for  the  field  in  the  future  is  how  the  Cdk-
  dependent association of Treslin and TopBP1 eventually leads to 
integration of Cdc45 into the replicative helicase. Although we 
have an increasingly complete accounting of the proteins that are 
necessary for replication in vertebrates, the actual biochemical 
functions of many of these proteins remain mysterious. Delineation 
of the regulatory relationship between Treslin and TopBP1 is a 
step forward toward a complete molecular understanding of rep-
lication in vertebrates.
Materials and methods
Cell culture and synchronization
U2OS cells were cultured in DME supplemented with 10% FBS, 50 U/ml 
penicillin, and 50 µg/ml streptomycin. For mitotic arrest, cells were treated 
with 0.2 µg/ml nocodazole for 18 h. Mitotically arrested cells were shaken 
off plates, washed twice with DME, and plated in fresh medium. For experi-
ments involving inhibition of Cdk2, 25 µM roscovitine was added to cultures. 
Conditions for treatment of U2OS cells with control and Treslin siRNA 
(Stealth  siRNA;  Invitrogen)  were  previously  described  (Kumagai  et  al., 
2010). For the experiments in this study, we used Treslin siRNA #1 
(5-GACCUGAGAGAAGAUUCAGAAGUUA-3).
Plasmids
pcDNA5/TO-Treslin-Myc (encoding Treslin with a Myc3–nuclear localiza-
tion sequence tag at the C-terminal end) was created from pcDNA5/
TO-Treslin, which contains silent mutations that render Treslin resistant to the 
siRNA used in this study. The sequence encoding the Myc3–nuclear local-
ization sequence tag was produced by PCR-based methods using DNA 
polymerase (Phusion; New England Biolabs, Inc.) and ligated to the 3 end of 
the Treslin cDNA. Deletion mutants were created by PCR-based methods. Point 
mutations  were  created  with  the  QuikChange  kit  using  Pfu  DNA  poly-
merase (Agilent Technologies). All mutations were confirmed by DNA se-
quencing. A human Cdc45 cDNA was isolated by PCR from a human 
placental cDNA library and cloned into pcDNA5/TO.
Production of U2OS cell lines expressing Treslin and its mutants
U2OS T-REx cells (obtained from T.C. Spelsberg, Mayo Clinic, Rochester, 
MN) were maintained in the presence of 5 µg/ml Blasticidin S. These cells 
were transfected with pcDNA5/TO encoding various siRNA-resistant forms 
of wild-type and mutant Treslin. Cells were selected with 200 µg/ml Hygro-
mycin B and 5 µg/ml Blasticidin S. Single colonies that expressed the desired 
protein upon addition of doxycycline were isolated and used for analysis.
Antibodies
Anti–human Treslin antibodies were previously described (Kumagai et al., 
2010). Anti-Myc (ab9106), anti-FLAG (M2), anti–human TopBP1 (A300-
111A), anti–human Cdc45 (H-300), and anti-tubulin antibodies (DM1A) 
were obtained from Abcam, Agilent Technologies, Bethyl Laboratories, Inc., 
Santa Cruz Biotechnology, Inc., and EMD, respectively. Anti–human Treslin 
phospho-S1000 antibodies were produced in rabbits against the phospho-
peptide CGVVEE(pS)PEKGD in a commercial facility (Covance), affinity puri-
fied with the phosphopeptide, and absorbed with the nonphosphorylated 
version of this peptide.
Immunoprecipitation
U2OS cells were harvested and lysed in a buffer containing 20 mM Hepes-
KOH, pH 7.5, 500 mM NaCl, 0.5% Triton X-100, 5 mM EDTA, 1 mM DTT, 
10 mM -glycerolphosphate, 1 mM NaF, 0.1 mM vanadate, 0.6 µM tauto-
mycin, 10 µg/ml each of pepstatin, chymostatin, and leupeptin, and 1 mM   
PMSF. Lysates were cleared by centrifugation at 16,000 g for 10 min.   
Supernatants were diluted with 2.3 vol of 20 mM Hepes-KOH, pH 7.5, 
and cleared by centrifugation at 16,000 g for 10 min. Cell lysates were 
immunoprecipitated in the presence of 50 µg/ml ethidium bromide for 
1.5 h with either anti–human Treslin or anti–human TopBP1 antibodies 
bound to protein A Dynabeads (Invitrogen). After the incubation, beads 
were  washed  three  times  with  Hepes-buffered  saline  (HBS;  10  mM 
Hepes-KOH, pH 7.5, and 150 mM NaCl) containing 0.5% Triton X-100.
sequence comparisons between Treslin and Sld3 (Sanchez-Pulido 
et al., 2010). Mutagenesis of the second residue in Treslin did not 
appear to affect binding to TopBP1 (and we have not detected 
phosphorylation of this site in mass spectrometric analyses). Thus, 
S1000 stands out as an especially important site of phosphory-
lation in Treslin.
Another important function of yeast Sld3 involves its 
interaction with Cdc45 (Kamimura et al., 2001; Tanaka et al., 
2007b). In this study, we have established yet another similarity 
between Treslin and Sld3 by showing that Treslin interacts well 
with Cdc45. In yeast, Sld3 and Cdc45 can associate initially 
with chromatin in the absence of S-Cdk activity (Kamimura et al., 
2001; Yabuuchi et al., 2006). Likewise, Treslin binds robustly to 
chromatin in egg extracts that have been treated with the Cdk 
inhibitor p27 (Kumagai et al., 2010). However, there appear to 
be some differences between the yeast and vertebrate systems. In 
particular, association of Cdc45 with chromatin in X. laevis egg 
extracts does depend on Cdk activity.
Overall, it appears that vertebrate Treslin and budding yeast 
Sld3 share many of their most important functional characteristics. 
Both proteins are able to associate with chromatin in the absence of 
S-Cdk activity. Each protein interacts specifically with Dpb11/
TopBP1, and this interaction requires Cdk-dependent phosphoryla-
tion. Both polypeptides associate with Cdc45 and are necessary for 
incorporation of Cdc45 into the replicative helicase. Finally, both 
proteins are essential for DNA replication. Interestingly, Treslin 
and Sld3 have retained these key properties despite significant 
Figure 8.  Treslin interacts with Cdc45 in human cells. (A) Treslin (1–921)-
Myc and human Cdc45 were transiently expressed in U2OS cells. Cell   
lysates (lane 1) were immunoprecipitated (IP) with either control anti-
bodies (lane 2) or anti–human Cdc45 antibodies (lane 3) and immuno-
blotted for the Myc tag (top) or Cdc45 (bottom). (B) Benzonase-digested 
nuclear lysates (lane 1) from interphase X. laevis egg extracts were immuno-
precipitated with control (lane 2), anti-Cdc45 (lane 3), and anti-Treslin 
antibodies (lane 4). The samples were immunoblotted for Treslin (top) and 
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then were sonicated. The lysates were clarified by centrifugation for 10 min 
at 22,000 g and incubated with nickel agarose beads for 2 h. The proteins 
were eluted with 150 mM imidazole in HBS. To produce a GST fusion protein 
containing amino acids 989–1,011 of human Treslin and the S1000A mu-
tant of this peptide, the appropriate DNA was amplified by PCR and cloned 
into pGEX4T-3 that had been digested with BamHI and EcoRI. These GST 
fusion proteins were prepared in bacteria as described previously (Lee et al., 
2005). GST-p27 was prepared in the same manner.
In vitro phosphorylation assays
Human Cdk2 and His6-tagged human cyclin E proteins were expressed sepa-
rately  in  baculovirus-infected  Sf9  cells.  Lysates  from  Cdk2-expressing  cells 
were mixed with His6–cyclin E that had been bound to nickel agarose beads. 
The mixtures were incubated at RT in the presence of 0.5 mM ATP and 10 mM 
MgCl2 for 20 min as previously described (Shou and Dunphy, 1996). The ac-
tive Cdk2–cyclin E complex was isolated from the nickel beads by elution with 
150 mM imidazole in HBS. For typical assays, Cdk2–cyclin E was incubated 
for 5 min with 1 µg substrate in a volume of 20 µl containing 10 mM Tris-HCl, 
pH 7.5, 1 µCi -[
32P]ATP, 10 µM ATP, 10 mM MgCl2, and 1 mM DTT. For re-
actions lacking -[
32P]ATP, the concentration of ATP was increased to 1 mM, 
and the incubation was performed for 30 min. Reactions were stopped by the 
addition of SDS gel sample buffer. Samples were subjected to SDS-PAGE and 
analyzed by phosphorimaging or immunoblotting, as appropriate.
MS analysis
Treslin was isolated by incubating a FLAG-tagged truncation of TopBP1 
containing BRCT domains I–VI in X. laevis nuclear lysates (Kumagai et al., 
2010). This fragment was bound to anti-FLAG antibodies that had been 
coupled to protein G Dynabeads. After washing the beads three times 
with 20 mM Hepes-KOH, pH 7.5, 80 mM NaCl, 2.5 mM EGTA, and 
0.1% NP-40 and once with 20 mM Hepes-KOH, pH 7.5, the proteins 
were eluted with SDS sample buffer. After gel separation, the selected gel 
band was in-gel digested with trypsin as previously described (Shevchenko 
et al., 2006). Recovered peptides were extracted with two changes of 
5% formic acid and 50% acetonitrile, and pooled extracts were dried 
down in a vacuum centrifuge. Dried peptide extracts were redissolved in 
15 µl of 5% acetic acid, sonicated, and analyzed by liquid chromatog-
raphy MS/MS.
Liquid  chromatography  MS/MS  was  performed  on  a  nanoLC 
  system (Ultimate3000; Dionex) interfaced online with a hybrid mass 
spectrometer (LTQ Orbitrap; Thermo Fisher Scientific) via the robotic 
nanoflow ion source TriVersa (Advion BioSciences) as previously described   
(Junqueira et al., 2008). To minimize column memory, several washing 
steps and blanks were introduced before each run. Spectra acquired during 
the last blank run were searched against a protein sequence database.
Acquired MS/MS spectra were first converted to the Mascot ge-
neric format and then searched against a full protein database (National 
Center for Biotechnology Information) and against the sequence of Treslin 
using MASCOT software (v.2.2.0; Matrix Science) under the following 
settings: mass tolerance was set as ±10 ppm for precursors and ±0.5 D 
for fragments; variable modification was Propionamide (C), Carbami-
domethyl (C), and Oxidation (M); and no enzyme specificity (for the 
search against Treslin sequence only) or trypsin (for the search against 
the full National Center for Biotechnology Information database). All hits 
with peptide ion scores >25 were then manually evaluated.
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